Comprehensive Stock Comparison
Compare Solventum Corporation (SOLV) vs AMN Healthcare Services, Inc. (AMN) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | SOLV | 0.9% revenue growth vs AMN's -21.3% |
| Value | AMN | Lower P/E (9.6x vs 11.5x) |
| Quality / Margins | SOLV | 18.7% net margin vs AMN's -3.5% |
| Stability / Safety | SOLV | Beta 0.97 vs AMN's 1.00, lower leverage |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | SOLV | -7.0% vs AMN's -23.1% |
| Efficiency (ROA) | SOLV | 10.9% ROA vs AMN's -4.6%, ROIC 16.9% vs -3.9% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Solventum is a healthcare company that develops, manufactures, and commercializes medical solutions across four main segments. It generates revenue primarily from medical surgical supplies (~40% of sales), dental products (~25%), health information systems software (~20%), and purification/filtration technologies (~15%). The company benefits from its established brand recognition and comprehensive product portfolio—spanning from wound care to dental orthodontics—which creates switching costs for healthcare providers.
AMN Healthcare is a leading healthcare staffing and workforce solutions company that connects healthcare facilities with temporary and permanent medical professionals. It generates revenue primarily through staffing services—with nurse and allied staffing making up the largest segment—alongside physician placement and technology-enabled workforce management solutions. The company's scale, extensive network of healthcare professionals, and established relationships with thousands of healthcare facilities create significant barriers to entry for competitors.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
SOLV leads in 4 of 6 categories (Financial Metrics, Profitability & Efficiency). AMN leads in 1 (Valuation Metrics).
Financial Metrics (TTM)
SOLV is the larger business by revenue, generating $8.3B annually — 3.0x AMN's $2.7B. SOLV is the more profitable business, keeping 18.7% of every revenue dollar as net income compared to AMN's -3.5%. On growth, AMN holds the edge at +1.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SOLVSolventum Corpora… | AMNAMN Healthcare Se… |
|---|---|---|
| RevenueTrailing 12 months | $8.3B | $2.7B |
| EBITDAEarnings before interest/tax | $2.9B | $25M |
| Net IncomeAfter-tax profit | $1.6B | -$96M |
| Free Cash FlowCash after capex | -$9M | $242M |
| Gross MarginGross profit ÷ Revenue | +53.5% | +28.3% |
| Operating MarginEBIT ÷ Revenue | +26.2% | -2.0% |
| Net MarginNet income ÷ Revenue | +18.7% | -3.5% |
| FCF MarginFCF ÷ Revenue | -0.1% | +8.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.7% | +1.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +105.6% | +95.9% |
Valuation Metrics
On an enterprise value basis, SOLV's 7.8x EV/EBITDA is more attractive than AMN's 29.2x.
| Metric | SOLVSolventum Corpora… | AMNAMN Healthcare Se… |
|---|---|---|
| Market CapShares × price | $12.9B | $987M |
| Enterprise ValueMkt cap + debt − cash | $17.0B | $2.1B |
| Trailing P/EPrice ÷ TTM EPS | 8.36x | -5.06x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.54x | 9.57x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 7.81x | 29.18x |
| Price / SalesMarket cap ÷ Revenue | 1.55x | 0.33x |
| Price / BookPrice ÷ Book value/share | 2.58x | 1.05x |
| Price / FCFMarket cap ÷ FCF | — | 4.12x |
Profitability & Efficiency
SOLV delivers a 30.8% return on equity — every $100 of shareholder capital generates $31 in annual profit, vs $-15 for AMN. SOLV carries lower financial leverage with a 1.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMN's 1.55x. On the Piotroski fundamental quality scale (0–9), SOLV scores 6/9 vs AMN's 4/9, reflecting solid financial health.
| Metric | SOLVSolventum Corpora… | AMNAMN Healthcare Se… |
|---|---|---|
| ROE (TTM)Return on equity | +30.8% | -14.9% |
| ROA (TTM)Return on assets | +10.9% | -4.6% |
| ROICReturn on invested capital | +16.9% | -3.9% |
| ROCEReturn on capital employed | +19.0% | -5.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 1.00x | 1.55x |
| Net DebtTotal debt minus cash | $4.2B | $1.1B |
| Cash & Equiv.Liquid assets | $878M | $11M |
| Total DebtShort + long-term debt | $5.0B | $1.1B |
| Interest CoverageEBIT ÷ Interest expense | 5.62x | -1.39x |
Total Returns (with DRIP)
A $10,000 investment in SOLV five years ago would be worth $9,275 today (with dividends reinvested), compared to $2,553 for AMN. Over the past 12 months, SOLV leads with a -7.0% total return vs AMN's -23.1%. The 3-year compound annual growth rate (CAGR) favors SOLV at -2.5% vs AMN's -40.0% — a key indicator of consistent wealth creation.
| Metric | SOLVSolventum Corpora… | AMNAMN Healthcare Se… |
|---|---|---|
| YTD ReturnYear-to-date | -6.1% | +28.8% |
| 1-Year ReturnPast 12 months | -7.0% | -23.1% |
| 3-Year ReturnCumulative with dividends | -7.2% | -78.4% |
| 5-Year ReturnCumulative with dividends | -7.3% | -74.5% |
| 10-Year ReturnCumulative with dividends | -7.2% | -31.5% |
| CAGR (3Y)Annualised 3-year return | -2.5% | -40.0% |
Risk & Volatility
SOLV is the less volatile stock with a 0.97 beta — it tends to amplify market swings less than AMN's 1.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SOLV currently trades 84.1% from its 52-week high vs AMN's 71.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SOLVSolventum Corpora… | AMNAMN Healthcare Se… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.97x | 1.00x |
| 52-Week HighHighest price in past year | $88.20 | $27.17 |
| 52-Week LowLowest price in past year | $60.70 | $14.87 |
| % of 52W HighCurrent price vs 52-week peak | +84.1% | +71.7% |
| RSI (14)Momentum oscillator 0–100 | 50.9 | 50.8 |
| Avg Volume (50D)Average daily shares traded | 788K | 1.1M |
Analyst Outlook
Wall Street rates SOLV as "Buy" and AMN as "Buy". Consensus price targets imply 29.1% upside for SOLV (target: $96) vs 17.5% for AMN (target: $23).
| Metric | SOLVSolventum Corpora… | AMNAMN Healthcare Se… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $95.80 | $22.88 |
| # AnalystsCovering analysts | 11 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 24 | Feb 26 | Change |
|---|---|---|---|
| Solventum Corporati… (SOLV) | 100 | 96.14 | -3.9% |
| AMN Healthcare Serv… (AMN) | 100 | 34.99 | -65.0% |
Solventum Corporati… (SOLV) returned -7% over 5 years vs AMN Healthcare Serv… (AMN)'s -74%.
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Solventum Corporati… (SOLV) | $8.2B | $8.3B | +1.9% |
| AMN Healthcare Serv… (AMN) | $1.9B | $3.0B | +56.9% |
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Solventum Corporati… (SOLV) | 17.9% | 18.7% | +4.6% |
| AMN Healthcare Serv… (AMN) | 5.6% | -4.9% | -188.5% |
Chart 4P/E Ratio History — 7 Years
| Stock | 2017 | 2023 | Change |
|---|---|---|---|
| AMN Healthcare Serv… (AMN) | 18.4 | 14 | -23.9% |
AMN Healthcare Services, Inc. has traded in a 10x–46x P/E range over 7 years; current trailing P/E is ~-5x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Solventum Corporati… (SOLV) | 8.47 | 8.88 | +4.8% |
| AMN Healthcare Serv… (AMN) | 2.15 | -3.85 | -279.1% |
Chart 6Free Cash Flow — 5 Years
Solventum Corporation generated $-10M FCF in 2025 (-101% vs 2021). AMN Healthcare Services, Inc. generated $240M FCF in 2024 (-5% vs 2021).
SOLV vs AMN: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is SOLV or AMN a better buy right now?
Solventum Corporation (SOLV) offers the better valuation at 8.4x trailing P/E (11.5x forward), making it the more compelling value choice. Analysts rate Solventum Corporation (SOLV) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SOLV or AMN?
On forward P/E, AMN Healthcare Services, Inc. is actually cheaper at 9.6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SOLV or AMN?
Over the past 5 years, Solventum Corporation (SOLV) delivered a total return of -7.3%, compared to -74.5% for AMN Healthcare Services, Inc. (AMN). A $10,000 investment in SOLV five years ago would be worth approximately $9K today (assuming dividends reinvested). Over 10 years, the gap is even starker: SOLV returned -7.2% versus AMN's -31.5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SOLV or AMN?
By beta (market sensitivity over 5 years), Solventum Corporation (SOLV) is the lower-risk stock at 0.97β versus AMN Healthcare Services, Inc.'s 1.00β — meaning AMN is approximately 3% more volatile than SOLV relative to the S&P 500. On balance sheet safety, Solventum Corporation (SOLV) carries a lower debt/equity ratio of 100% versus 155% for AMN Healthcare Services, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — SOLV or AMN?
Solventum Corporation (SOLV) is the more profitable company, earning 18.7% net margin versus -4.9% for AMN Healthcare Services, Inc. — meaning it keeps 18.7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SOLV leads at 26.2% versus -3.4% for AMN. At the gross margin level — before operating expenses — SOLV leads at 53.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is SOLV or AMN more undervalued right now?
On forward earnings alone, AMN Healthcare Services, Inc. (AMN) trades at 9.6x forward P/E versus 11.5x for Solventum Corporation — 2.0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SOLV: 29.1% to $95.80.
07Which pays a better dividend — SOLV or AMN?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is SOLV or AMN better for a retirement portfolio?
For long-horizon retirement investors, Solventum Corporation (SOLV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.97)). Both have compounded well over 10 years (SOLV: -7.2%, AMN: -31.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between SOLV and AMN?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: SOLV is a mid-cap deep-value stock; AMN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.